1. Home
  2. OCFC vs IVA Comparison

OCFC vs IVA Comparison

Compare OCFC & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCFC
  • IVA
  • Stock Information
  • Founded
  • OCFC 1902
  • IVA 2011
  • Country
  • OCFC United States
  • IVA France
  • Employees
  • OCFC N/A
  • IVA N/A
  • Industry
  • OCFC Major Banks
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • OCFC Finance
  • IVA Health Care
  • Exchange
  • OCFC Nasdaq
  • IVA Nasdaq
  • Market Cap
  • OCFC 944.6M
  • IVA 769.0M
  • IPO Year
  • OCFC 1996
  • IVA 2020
  • Fundamental
  • Price
  • OCFC $17.97
  • IVA $5.26
  • Analyst Decision
  • OCFC Buy
  • IVA Strong Buy
  • Analyst Count
  • OCFC 4
  • IVA 6
  • Target Price
  • OCFC $21.25
  • IVA $15.33
  • AVG Volume (30 Days)
  • OCFC 252.8K
  • IVA 74.0K
  • Earning Date
  • OCFC 10-16-2025
  • IVA 09-26-2025
  • Dividend Yield
  • OCFC 4.52%
  • IVA N/A
  • EPS Growth
  • OCFC N/A
  • IVA N/A
  • EPS
  • OCFC 1.41
  • IVA N/A
  • Revenue
  • OCFC $376,075,000.00
  • IVA $14,591,573.00
  • Revenue This Year
  • OCFC N/A
  • IVA $80.35
  • Revenue Next Year
  • OCFC $13.22
  • IVA N/A
  • P/E Ratio
  • OCFC $12.57
  • IVA N/A
  • Revenue Growth
  • OCFC 0.00
  • IVA N/A
  • 52 Week Low
  • OCFC $14.29
  • IVA $1.53
  • 52 Week High
  • OCFC $21.87
  • IVA $6.50
  • Technical
  • Relative Strength Index (RSI)
  • OCFC 51.10
  • IVA 54.60
  • Support Level
  • OCFC $17.55
  • IVA $5.21
  • Resistance Level
  • OCFC $18.32
  • IVA $5.78
  • Average True Range (ATR)
  • OCFC 0.49
  • IVA 0.36
  • MACD
  • OCFC -0.06
  • IVA -0.09
  • Stochastic Oscillator
  • OCFC 30.88
  • IVA 3.85

About OCFC OceanFirst Financial Corp.

OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management products and services.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: